PolyCera® Secures Phase Two of Large-Scale Lithium Extraction Initiative in Tibet, China

PolyCera® Secures Phase Two of Large-Scale Lithium Extraction Initiative in Tibet, China PolyCera®, a brand under PSP.US, a renowned global leader in next-generation membrane technology, has proudly announced its selection for the second phase of the Salt Lake Lithium Extraction…

Read MorePolyCera® Secures Phase Two of Large-Scale Lithium Extraction Initiative in Tibet, China

Perma-Pipe International Holdings, Inc. Announces CEO Retirement and Names Saleh Sagr as New President

Perma-Pipe International Holdings,has announced that Chief Executive Officer (CEO) David Mansfield will retire on or before November 8, 2025. To ensure a seamless leadership transition, the company has appointed Saleh Sagr as President, effective immediately. Mr. Mansfield will continue in…

Read MorePerma-Pipe International Holdings, Inc. Announces CEO Retirement and Names Saleh Sagr as New President

Ethylene Dichloride Market Outlook 2024–2030 Industrial Growth in Emerging Economies Drives Rising Demand

The global ethylene dichloride (EDC) market is experiencing significant growth, driven by advancements in production technologies, increasing demand for polyvinyl chloride (PVC), and the rapid industrialization of emerging economies. Ethylene Dichloride This article provides an in-depth analysis of the market…

Read MoreEthylene Dichloride Market Outlook 2024–2030 Industrial Growth in Emerging Economies Drives Rising Demand

LabTAG & eLabNext Unveil DYMO® LabelWriter™ 5-Series Add-On for Effortless Lab Labeling

GA International Expands Laboratory Labeling Solutions with eLabNext Integration for Dymo® LabelWriter™ 5-Series LabTAG GA International, a global leader in laboratory identification solutions under its LabTAG brand, has LabTAG announced an exciting new advancement in laboratory labeling technology. The company…

Read MoreLabTAG & eLabNext Unveil DYMO® LabelWriter™ 5-Series Add-On for Effortless Lab Labeling

Wacker Biotech Partners with RNAV8 Bio to Advance mRNA Therapeutics Innovation

Wacker Biotech, a globally recognized contract development and manufacturing organization (CDMO) and a wholly owned subsidiary of Wacker Chemie AG, has officially entered into a strategic collaboration with RNAV8 Bio, a Boston-based biotechnology company specializing in mRNA engineering. This partnership…

Read MoreWacker Biotech Partners with RNAV8 Bio to Advance mRNA Therapeutics Innovation